[Effects of perioperative use of renin-angiotensin system inhibitor on renal function and clinical outcomes in patients undergoing coronary artery bypass grafting surgery].
The perioperative use of RASi can reduce the risk of postoperative AKI in patients undergoing CABG, has a certain renal protective effect, but is not associated with short-term or long-term death risk after surgery.
Authors
- Su Yuan (ORCID: https://orcid.org/0000-0003-3924-7548)
- Hongyan Zhou (ORCID: https://orcid.org/0000-0002-1868-8080)
- Bei Zhang (ORCID: https://orcid.org/0000-0003-1852-5844)
- Xiaoting Su (ORCID: https://orcid.org/0000-0002-2501-0606)
- Heng Zhang (ORCID: https://orcid.org/0000-0001-6628-6011)
- Juan Du (ORCID: https://orcid.org/0000-0002-0271-1709)
- Nan Cheng
- Zhongchen Li (ORCID: https://orcid.org/0000-0002-7469-4514)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-10-01
- DOI
- https://doi.org/10.3760/cma.j.cn121430-20240801-00652
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article